Psoriasis is a chronic inflammatory skin disease unique to humans. In this issue of the JCI, 2 studies of very different mouse models of psoriasis both report that macrophages play a key role in inducing psoriasis-like skin disease. Psoriasis is clearly a polygenic, inherited disease of uncontrolled cutaneous inflammation. The debate that currently rages in the field is whether psoriasis is a disease of autoreactive T cells or whether it reflects an intrinsic defect within the skin — or both. However, these questions have proven difficult to dissect using molecular genetic tools. In the current studies, the authors have used 2 different animal models to address the role of macrophages in disease pathogenesis: Wang et al. use a mouse model in which inflammation is T cell dependent, whereas the model used by Stratis et al. is T cell independent (see the related articles beginning on pages 2105 and 2094, respectively). Strikingly, both groups report an important contribution by macrophages, implying that macrophages can contribute to both epithelial-based and T cell–mediated pathways of inflammation.
Rachael A. Clark, Thomas S. Kupper
Title and authors | Publication | Year |
---|---|---|
Roles for Exosomes in the Pathogenesis, Drug Delivery and Therapy of Psoriasis
Chen Y, Liu H, He Y, Yang B, Lu W, Dai Z |
Pharmaceutics | 2025 |
Histone Modifications and DNA Methylation in Psoriasis: A Cellular Perspective.
Pan J, Chen S, Chen X, Song Y, Cheng H |
Clinical reviews in allergy & immunology | 2025 |
Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol
Xiong BB, Zhuo YM, Wang H, Zheng QL, Tang F, Huang Q, Yao M |
Frontiers in Pharmacology | 2025 |
A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation.
Wang Q, Yang X, Yuan R, Shen A, Wang P, Li H, Zhang J, Tian C, Jiang Z, Li W, Dong S |
Nature Communications | 2024 |
Integrative analysis of RNA-sequencing and microarray for the identification of adverse effects of UVB exposure on human skin.
Jang Y, Na HW, Shin DY, Lee J, Han JP, Kim HS, Kim SJ, Choi EJ, Lee C, Hong YD, Kim HJ, Seo YR |
Frontiers in public health | 2024 |
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
Mehta H, Narang T, Dogra S, Handa S, Hatwal J, Batta A |
Vascular Health and Risk Management | 2024 |
Macrophage Functions in Psoriasis: Lessons from Mouse Models
Nazimek K, Bryniarski K |
International journal of molecular sciences | 2024 |
Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma
Liu L, Yin P, Yang R, Zhang G, Wu C, Zheng Y, Wu S, Liu M |
Frontiers in immunology | 2024 |
NETosis of psoriasis: a critical step in amplifying the inflammatory response.
Zhang J, Feng Y, Shi D |
Frontiers in immunology | 2024 |
Exploring shared mechanisms between ulcerative colitis and psoriasis and predicting therapeutic natural compounds through bioinformatics and molecular docking
Yang Y, Gong Z, Yang J, Cai Y, Hong S, Mao W, Guo Z, Qiu M, Fan Z, Cui B |
Heliyon | 2024 |
Transcriptional regulation on effector T cells in the pathogenesis of psoriasis.
Qu Y, Li D, Xiong H, Shi D |
European Journal of Medical Research | 2023 |
M2‐like macrophages polarized by Foxp3− Treg‐of‐B cells ameliorate imiquimod‐induced psoriasis
Huang J, Lin Y, Wang L, Chiang B |
Journal of Cellular and Molecular Medicine | 2023 |
Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.
Wang CY, Wang CW, Chen CB, Chen WT, Chang YC, Hui RC, Chung WH |
International journal of molecular sciences | 2023 |
Topical Diacerein Decreases Skin and Splenic CD11c(+) Dendritic Cells in Psoriasis.
Brunner SM, Ramspacher A, Rieser C, Leitner J, Heil H, Ablinger M, Tevini J, Wimmer M, Koller A, Piñón Hofbauer J, Felder TK, Bauer JW, Kofler B, Lang R, Wally V |
International journal of molecular sciences | 2023 |
Identification of PANoptosis-related biomarkers and immune infiltration characteristics in psoriasis
Lu L, Zhang B, Shi M, Liu A |
Medicine | 2023 |
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment
S Mishra, M Charan, R Shukla, P Agarwal, S Misri, A Verma, D Ahirwar, J Siddiqui, K Kaul, N Sahu, K Vyas, A Garg, A Khan, W Miles, J Song, N Bhutani, R Ganju |
Journal of Experimental & Clinical Cancer Research | 2022 |
Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.
Kamata M, Tada Y |
Frontiers in immunology | 2022 |
TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.
Vickman RE, Aaron-Brooks L, Zhang R, Lanman NA, Lapin B, Gil V, Greenberg M, Sasaki T, Cresswell GM, Broman MM, Paez JS, Petkewicz J, Talaty P, Helfand BT, Glaser AP, Wang CH, Franco OE, Ratliff TL, Nastiuk KL, Crawford SE, Hayward SW |
Nature Communications | 2022 |
The phytochemical profiling, pharmacological activities, and safety of malva sylvestris: a review
Batiha GE, Tene ST, Teibo JO, Shaheen HM, Oluwatoba OS, Teibo TK, Al-kuraishy HM, Al-Garbee AI, Alexiou A, Papadakis M |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2022 |
Transcriptional inhibition of STAT1 functions in the nucleus alleviates Th1 and Th17 cell-mediated inflammatory diseases.
Park J, Son MJ, Ho CC, Lee SH, Kim Y, An J, Lee SK |
Frontiers in immunology | 2022 |
Iontophoresis of Biological Macromolecular Drugs.
Hasan M, Khatun A, Kogure K |
Pharmaceutics | 2022 |
Cell-Inspired Biomaterials for Modulating Inflammation
EC Bender, CA Kraynak, W Huang, LJ Suggs |
Tissue Engineering Part B: Reviews | 2021 |
Interferon Kappa Is a Rheostat for Development of Psoriasiform Inflammation
M Gharaee-Kermani, SN Estadt, LC Tsoi, SJ Wolf, J Liu, X Xing, J Theros, TJ Reed, L Lowe, D Gruszka, NL Ward, JE Gudjonsson, JM Kahlenberg |
Journal of Investigative Dermatology | 2021 |
2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation.
Chuang SY, Chen CY, Yang SC, Alalaiwe A, Lin CH, Fang JY |
Frontiers in immunology | 2021 |
Green Phellodendri Chinensis Cortex-based carbon dots for ameliorating imiquimod-induced psoriasis-like inflammation in mice.
Zhang M, Cheng J, Hu J, Luo J, Zhang Y, Lu F, Kong H, Qu H, Zhao Y |
Journal of nanobiotechnology | 2021 |
DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis.
Sanz-Garcia A, Reolid A, Fisas LH, Muñoz-Aceituno E, Llamas-Velasco M, Sahuquillo-Torralba A, Botella-Estrada R, García-Martínez J, Navarro R, Daudén E, Abad-Santos F, Ovejero-Benito MC |
Acta Dermato Venereologica | 2021 |
Identification of Hub Genes and Immune Infiltration in Psoriasis by Bioinformatics Method.
Su W, Wei Y, Huang B, Ji J |
Frontiers in Genetics | 2021 |
Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages
BP Gaire, CH Lee, W Kim, A Sapkota, DY Lee, JW Choi |
Cells | 2020 |
Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation
S Thatikonda, V Pooladanda, DK Sigalapalli, C Godugu |
Cell Death and Disease | 2020 |
Regulating the Polarization of Macrophages: A Promising Approach to Vascular Dermatosis
H Peng, D Xian, J Liu, S Pan, R Tang, J Zhong |
Journal of Immunology Research | 2020 |
Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir -/- murine psoriasis
C Qie, J Jiang, W Liu, X Hu, W Chen, X Xie, J Liu |
Theranostics | 2020 |
Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development
D Queen, C Ediriweera, L Liu |
Frontiers in Cell and Developmental Biology | 2019 |
Phosphatidylglycerol Inhibits Toll-Like Receptor–Mediated Inflammation by Danger-Associated Molecular Patterns
V Choudhary, R Uaratanawong, RR Patel, H Patel, W Bao, B Hartney, E Cohen, X Chen, Q Zhong, CM Isales, WB Bollag |
Journal of Investigative Dermatology | 2019 |
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
Madonna, Girolomoni, Dinarello, Albanesi |
International journal of molecular sciences | 2019 |
Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis
Yvonne Baumer, Qimin Ng, Gregory Sanda, Amit Dey, Heather Teague, Alexander Sorokin, Pradeep Dagur, Silverman Joanna, Charlotte Harrington, Justin Rodante, Shawn Rose, Nevin Varghese, Agastya Belur, Aditya Goyal, Joel M. Gelfand, Danielle Springer, Christopher Bleck, Crystal Thomas, Zu Xi Yu, Mårten CG Winge, Howard Kruth, Peter Marinkovich, Aditya Joshi, Martin Playford, Nehal Mehta |
JCI Insight | 2018 |
Potential Immunological Links Between Psoriasis and Cardiovascular Disease
AP Sajja, AA Joshi, HL Teague, AK Dey, NN Mehta |
Frontiers in immunology | 2018 |
IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis
C Bridgewood, GW Fearnley, A Berekmeri, P Laws, T Macleod, S Ponnambalam, M Stacey, A Graham, M Wittmann |
Frontiers in immunology | 2018 |
Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
JC Chamcheu, IA Siddiqui, VM Adhami, S Esnault, DJ Bharali, AS Babatunde, S Adame, RJ Massey, GS Wood, BJ Longley, SA Mousa, H Mukhtar |
International Journal of Nanomedicine | 2018 |
Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice
YJ Jeon, SK Sah, HS Yang, JH Lee, J Shin, TY Kim |
Experimental & molecular medicine | 2017 |
Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis
I Lorthois, D Asselineau, N Seyler, R Pouliot |
Mediators of Inflammation | 2017 |
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA
JL Cohen, Y Shen, M Aouadi, P Vangala, M Tencerova, SU Amano, SM Nicoloro, JC Yawe, MP Czech |
Molecular Pharmaceutics | 2016 |
Current knowledge on psoriasis and autoimmune diseases
T McCormick, N Ayala-Fontanez, D Soler |
Psoriasis: Targets and Therapy | 2016 |
Tumor Progression Locus 2 (Tpl2) Kinase Promotes Chemokine Receptor Expression and Macrophage Migration during Acute Inflammation
SM Rowley, T Kuriakose, LM Dockery, T Tran-Ngyuen, AD Gingerich, L Wei, WT Watford |
The Journal of biological chemistry | 2014 |
Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammation
HC Pal, JC Chamcheu, VM Adhami, GS Wood, CA Elmets, H Mukhtar, F Afaq |
The British journal of dermatology | 2014 |
Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice
I Lerner, E Zcharia, T Neuman, E Hermano, AM Rubinstein, I Vlodavsky, M Elkin |
Cellular and Molecular Life Sciences | 2013 |
Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases.
Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB |
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology | 2013 |
Development of paclitaxel-TyroSpheres for topical skin treatment.
Kilfoyle BE, Sheihet L, Zhang Z, Laohoo M, Kohn J, Michniak-Kohn BB |
Journal of Controlled Release | 2012 |
Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice
Q Li, F Ke, W Zhang, X Shen, Q Xu, H Wang, XZ Yu, Q Leng, H Wang |
PloS one | 2011 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Translational Perspectives on Psoriatic Arthritis
RITCHLIN CT, PROULX S, SCHWARZ ES |
The Journal of rheumatology. Supplement | 2009 |
Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice
J Menke, MY Hsu, KT Byrne, JA Lucas, WA Rabacal, BP Croker, XH Zong, ER Stanley, VR Kelley |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
Chemokine receptor antagonists: overcoming developmental hurdles
R Horuk |
Nature Reviews Drug Discovery | 2008 |
Immunologic misbehaviour in psoriasis
Ingo Haase |
Journal of Clinical Investigation | 2006 |